GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) today announced the company plans to participate in two upcoming investor conferences.
Senseonics’ management is scheduled to present at the Raymond James 39th Annual Institutional Investor Conference in Orlando, Florida on Wednesday, March 7, 2018 at 9:15am ET. Interested parties may access a live and recorded webcast of the presentation on the “Investor Relations” section of the company’s website at www.senseonics.com.
Senseonics’ management is scheduled to present at the Cowen 38th Annual Health Care Conference in Boston, Massachusetts on Wednesday, March 14, 2018 at 10:00am ET. Interested parties may access a live and recorded webcast of the presentation on the “Investor Relations” section of the company’s website at www.senseonics.com.
About Senseonics
Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of transformational glucose monitoring products designed to help people with diabetes confidently live their lives with ease. Senseonics' CGM systems, Eversense and Eversense XL, include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.
